Drug profile · INN
melphalan
ALKERAN
melphalan (ALKERAN) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — melphalan
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- ORAL
- Patents
- 0
- Programs
- 15
- Data quality
- 0.84
Quick answer
melphalan (ALKERAN) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is melphalan?
melphalan (ALKERAN) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for melphalan?
ALKERAN is a marketed brand name for melphalan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of melphalan?
melphalan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.